GLP-1 Providers in New Jersey (2026)

338 of the 444 sellers that publish a state list include New Jersey, the 40th-most of the 50 states and DC. 226 of them ship to all 50 states, and 3 serve 15 states or fewer. Across the 235 with a regular monthly price, the middle figure is $169/mo.

New Jersey Medicaid does not pay for GLP-1 drugs prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

Sellers and prices are broken out by drug on the semaglutide in New Jersey and tirzepatide in New Jersey pages.

Who Ships GLP-1s to New Jersey

1. WellMedRx $49/mo
2. Collective $59/mo
3. RxPepsDirect $64/mo

Lowest regular prices for New Jersey: WellMedRx at $49/mo, Collective at $59/mo and RxPepsDirect at $64/mo.

Smaller-footprint sellers that include New Jersey: Flo Clinic (2 states), FormidableMD (4 states) and Nava Health (15 states).

22 sellers that list 30 or more states leave New Jersey off, among them TeleCareSpot, Healthspan, OurView Health, RxION Health and TeleClinic.

Seller counts next door: Delaware 347, New York 369 and Pennsylvania 363.

Browse by medication

New Jersey Medicaid and GLP-1 Coverage

New Jersey Medicaid does not pay for GLP-1 drugs prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

• Wegovy to cut heart attack and stroke risk: covered with prior authorization (established cardiovascular disease: prior heart attack, prior stroke or TIA, symptomatic peripheral artery disease (ABI under 0.85, revascularization or amputation), positive nuclear stress test, ischemic cardiomyopathy, or prior revascularization; BMI of at least 27; prescribed by or with a cardiologist, vascular specialist or endocrinologist; kept on heart medicines; lifestyle counseling; no other GLP-1).
• Wegovy for the liver disease MASH: covered with prior authorization (fibrosis stage F2, F3).
• Zepbound for obstructive sleep apnea: covered with prior authorization.
• Weight-loss GLP-1s for adolescents: covered with prior authorization.

In 2025, New Jersey Medicaid paid for at least 165,515 GLP-1 prescriptions, including at least 64,809 for Ozempic, at least 3,829 for Wegovy, at least 37,880 for Mounjaro and at least 6,385 for Zepbound, about $151.3 million before manufacturer rebates. Drugs labeled for weight loss made up 8% of that spending.

Medicaid rules checked November 2026. Prescription counts: CMS State Drug Utilization Data. Check your eligibility

Specialist Clinics and Obesity in New Jersey

New Jersey has 1,170 practices in the federal provider registry that list obesity medicine, endocrinology or bariatric care, 12.31 per 100,000 residents (3rd of 51). By specialty: 585 bariatric, 577 endocrinology and 23 obesity medicine. About 27.7% of adults here had obesity in 2024 (CDC), the 46th-highest rate of the 50 states and DC. Measured against the median state, New Jersey has 0.56 times as much adult obesity per specialist practice.

Largest Cities in New Jersey

Frequently Asked Questions